Trial Profile
A Study to Evaluate the Safety and Efficacy of Fixed-Dose Combination of Olmesartan-medoxomil/amlodipine/hydrochlorothiazide In Patients with Essential Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Dec 2015
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil/amlodipine/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- 24 Dec 2015 New trial record